Volume 1, Issue 2

Ann Integrative Oncol. 2021;1(2):1009. | Research Article | Open Access
Abstract | Fulltext PDF

Post-Progression Therapy after Chemoradiation and Consolidation Pembrolizumab: An Analysis from the Hoosier Cancer Research Network LUN 14-179 Phase 2 Clinical Trial

Meagan Miller, Nasser Hanna, Shadia Jalal, Salma K Jabbour, Robin Zon, Goetz Kloecker, Michael Williamson, Karen Reckamp, Ebenezer Kio, Robert Langdon, Bamidele Adesunloye, Ryan Gentzler, Wael Harb, Radhika Walling, Christina Yeon, Marianna Koczywas and Greg Durm

Share This Article:


Subscribe to Our Newsletter